Longquan group gears up to take more gelatine market share
Gelatine food ingredient manufacturer Zhejiang Jiadeli Biotechnology Co Ltd, also known as Gaderi – based in the Longquan Economic Development Zone – is understood to have experienced significant growth and it is bullish about the future, expecting to take more market share in the coming years.
The company is a world-class manufacturer of high-quality gelatine tablets and gelatine biotechnology and in June 2019 it settled in the zone, located in Longquan – a county level city administered by Lishui, in East China's Zhejiang province.
The group makes gelatine tablets, powder and collagen peptides in China and it has now become the raw materials supplier of many renowned brands such as Starbucks and Daliyuan.
Gelatine is a baking ingredient that is high-protein and zero in fat which has been in high demand in the domestic market in recent years, while the core production technology was monopolized by Germany. As a result, Gaderi chairman Ye Youcang said he was eager to increase his group's market share.
According to Ye, in addition to the excellent water quality – which boosts the quality of gelatine – the most important reason to settle in Longquan was the support provided by the local government.
"After signing the contract, Longquan quickly helped us to solve problems with the plant, which made early production possible," Ye said.
With advanced production lines introduced, Gaderi has achieved a great leap forward in production quality and efficiency. "The annual output value reached 21 million yuan ($3.32 million) in 2020 and 50.5 million yuan in 2021, exceeding the expected targets," said general manager Sang Beibei.
Sang said the company's new plant would be completed in May this year and when fully ramped up, it was expected to achieve a breakthrough, with annual output worth 150 million yuan.
"In the past we relied on European imports and in future it is possible that Europe, in turn, will rely on us," Ye said.